Abstract:Diabetes, whether insulin-dependent or independent is a major cause of endothelial dysfunction and a leading risk factor for cardiovascular disease. While compelling evidence indicates that endothelial dysfunction is a precursor and contributor to cardiovascular disease, the etiology of diabetes-induced endothelial dysfunction remains ill-defined. Recently alteration in endothelial cell bioenergetics has emerged as a new contributor to vascular diseases. However, whether alterations in endothelial glycolysis, the main endothelial cell bioenergetic pathway contributes to endothelial dysfunction is unknown. Herein, we tested the hypothesis that diabetes-associated endothelial dysfunction involved increases in endothelial cells glycolysis and upregulation of its primary regulator, 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 3 (PFKFB3). Measurement of glycolytic activity via Seahorse analyzer in primary human aortic endothelial cells (HAEC) from control and diabetic patients revealed a significant increase in basal glycolysis in diabetic subjects (p<0.05). We also employed Akita mice, a mouse model of type 1 diabetes. Male Akita mice showed a diabetic phenotype with 3-folds increase in blood glucose. Seahorse analysis in intact aortic explants revealed a 1.7-fold increase in basal glycolysis and a 1.3-fold increase in maximal glycolysis in Akita mice (P<0.05). The increase in glycolysis was endothelial-derived as aortic denudation significantly decreased glycolysis in Akita mice and abolished the difference between groups. No significant difference in mitochondrial function was depicted in the mito-stress test between Akita and WT aortic explants (p>0.05). Additionally, endothelial cells extracted from aortas of Akita mice exhibited a 2-fold increase in PFKFB3 mRNA expression(P<0.05). Interestingly, inhibition of PFKFB3 using 3PO (20μM) restored endothelial function in Akita mice. Similarly, Non-obese diabetic females (NOD), a model for type-1 diabetes, showed 4-fold increases in PFKFB3 mRNA expression in aortic endothelial cells and impaired EDR which was restored with 3PO (p<0.05). To further evaluate the role of PFKFB3 in vascular endothelial function we overexpressed PFKFB3 in WT aortas with adenovirus (Ad-PFKFB3), and reported impaired aorta EDR(P<0.05). Transduction of HAEC with Ad-PFKFB3 showed a significant increase in ROS producing enzyme (NOX1). Also, inhibition of NOX1 using the selective inhibitor GKT771 restored EDR in Akita and Ad-PFKFB3-transduced WT aortas. In Conclusion, our data identified for the first time a role for endothelial glycolysis in the control of vascular relaxation and showed a crucial role of PFKFB3-mediated endothelial glycolysis in vascular endothelial dysfunction associated with Type-1 diabetes in males and females. The underlying mechanism potentially involves NOX1 as a downstream target for PFKFB3. Thus, Inhibitors of PFKFB3 could be a potential therapeutic target for diabetes-induced vascular endothelial dysfunction.

Increased ATP and ADO Overflow From Sympathetic Nerve Endings and Mesentery Endothelial Cells Plus Reduced Nitric Oxide Are Involved in Diabetic Neurovascular Dysfunction

Changes of Macrovascular Endothelial Ultrastructure and Gene Expression of Endothelial Nitric Oxide Synthase in Diabetic Rats

Impaired capsaicin-induced relaxation in diabetic mesenteric arteries

Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy

Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy

Angiotensin II-NADPH Oxidase-Derived Superoxide Mediates Diabetes-Attenuated Cell Excitability of Aortic Baroreceptor Neurons.

Nitric Oxide as a Potential Bridge Between the Metabolic and Vascular Hypotheses of Diabetic Neuropathy

Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes

Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve

Nitric Oxide Synthase Activity and Expression in Experimental Diabetic Neuropathy

Elevated Angiotensin Ii in Rat Nodose Ganglia Primes Diabetes-Blunted Arterial Baroreflex Sensitivity: Involvement of Nadph Oxidase-Derived Superoxide

Experimental Rat Models of Types 1 and 2 Diabetes Differ in Sympathetic Neuroaxonal Dystrophy

Impairment in Endothelial Bioenergetics Contributes to Diabetes-Induced Vascular Dysfunction.

Endothelial Nitric Oxide Synthase-Dependent Tyrosine Nitration Of Prostacyclin Synthase In Diabetes In Vivo

Involvement Of Nadph Oxidase-Derived Superoxide Anion In Diabetes-Blunted Aortic Baroreceptor Neuron Excitability

Functional Changes in Baroreceptor Afferent, Central and Efferent Components of the Baroreflex Circuitry in Type 1 Diabetic Mice (OVE26)

Blunted Excitability of Aortic Baroreceptor Neurons in Diabetic Rats: Involvement of Hyperpolarization-Activated Channel

Hypoglycaemia aggravates impaired endothelial-dependent vasodilation in diabetes by suppressing endothelial nitric oxide synthase activity and stimulating inducible nitric oxide synthase expression

Changes of Mesentery Microcirculation in Type 2 Diabetic Rats and Its Clinical Significance

Disruption of TRPV1-mediated coupling of coronary blood flow to cardiac metabolism in diabetic mice: role of nitric oxide and BK channels

Downregulation of Neuronal Nitric Oxide Synthase (nnos) Within the Paraventricular Nucleus in Ins2akita-Type-1 Diabetic Mice Contributes to Sympatho-Excitation